We noticed you’re blocking ads

Thanks for visiting MillennialEYE. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://millennialeye.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Digital Outsert | Nov/Dec '20

Break Free From Tradition with the AcrySof IQ PanOptix Trifocal IOL – Cathleen McCabe, MD

Cathleen McCabe, MD, doesn’t just live in a community of creative people—she’s one of them! As an avid glass artist and lover of the outdoors, Dr. McCabe can relate to her patients’ desire for a range of vision that supports their hobbies and lifestyles. Whether it’s the ability to enjoy hobbies or to video conference with friends and family, good vision is paramount. That’s why Dr. McCabe recommends the Alcon AcrySof IQ PanOptix Trifocal IOL.

No matter what activities my patients enjoy, they often require a range of vision, particularly from intermediate to near. So, I broke free from having to make them choose which distance was most important.

“Breaking free was all about increasing my patients’ visual independence and the option to get the most out of their hobbies and interests. I think about myself: I need good near and intermediate vision when I’m working in my glass workshop, and I depend on my distance vision when enjoying the outdoors. I may get a video call when I’m out on the water, and I need that near vision again to share the moment with a friend or family member.”

Dr. Cathy McCabe on Breaking Free:

Cathy McCabe, MD, realizes how important it is for her to be able to go between distance, intermediate, and near vision at any moment. That is why she chooses to offer the same visual independence to her patients with the AcrySof IQ PanOptix Trifocal IOL by Alcon. From detailed creative work to exploring the great outdoors, Dr. McCabe wants her patients to be able to comfortably adapt to any setting they are in.

With the PanOptix lens, 20/20 near, intermediate, and distance vision is now possible, making it my preferred lens for empowering patients.*, † ,1

“Many of my patients are musicians, artists, and crafters. There are many creative people here, and patients often tell me they’re involved in some kind of activity that requires very detailed near vision.”

It’s more important than ever to be independent and to be able to freely participate in all of our hobbies and interests.

“The ability to connect via technology has become a prominent part of our lives, and I suspect that video conferencing is here to stay. I want to make sure my patients can comfortably use their vision to connect, whether it’s virtually or in person.”

More surgeons on breaking free:

AcrySof® IQ PanOptix® Family of Trifocal IOLs

IMPORTANT PRODUCT INFORMATION

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

INDICATIONS: The AcrySof® IQ PanOptix® Trifocal IOLs include AcrySof® IQ PanOptix® and AcrySof® IQ PanOptix® Toric and are indicated for primary implantation in the capsular bag in the posterior chamber of the eye for the visual correction of aphakia in adult patients, with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing improved intermediate and near visual acuity, while maintaining comparable distance visual acuity with a reduced need for eyeglasses, compared to a monofocal IOL. In addition, the AcrySof® IQ PanOptix® Toric Trifocal IOL is indicated for the reduction of residual refractive astigmatism.

WARNINGS/PRECAUTIONS: Careful preoperative evaluation and sound clinical judgment should be used by the surgeon to decide the risk/benefit ratio before implanting a lens in a patient with any of the conditions described in the Directions for Use labeling. Physicians should target emmetropia and ensure that IOL centration is achieved.

For the AcrySof® IQ PanOptix® Toric Trifocal IOL, the lens should not be implanted if the posterior capsule is ruptured, if the zonules are damaged or if a primary posterior capsulotomy is planned. Rotation can reduce astigmatic correction. If necessary, lens repositioning should occur as early as possible prior to lens encapsulation.

Some visual effects may be expected due to the superposition of focused and unfocused multiple images. These may include some perceptions of halos or starbursts, as well as other visual symptoms. As with other multifocal IOLs, there is a possibility that visual symptoms may be significant enough that the patient will request explant of the multifocal IOL. A reduction in contrast sensitivity as compared to a monofocal IOL may be experienced by some patients and may be more prevalent in low lighting conditions. Therefore, patients implanted with multifocal IOLs should exercise caution when driving at night or in poor visibility conditions.

Patients should be advised that unexpected outcomes could lead to continued spectacle dependence or the need for secondary surgical intervention (e.g., intraocular lens replacement or repositioning).

As with other multifocal IOLs, patients may need glasses when reading small print or looking at small objects. Posterior capsule opacification (PCO) may significantly affect the vision of patients with multifocal IOLs sooner in its progression than patients with monofocal IOLs. Prior to surgery, physicians should provide prospective patients with a copy of the Patient Information Brochure, available from Alcon, informing them of possible risks and benefits associated with the AcrySof® IQ PanOptix® Trifocal IOLs.

ATTENTION: Reference the Directions for Use labeling for each IOL for a complete listing of indications, warnings and precautions.

*Based on mean value of binocular defocus curve at near, intermediate and distance at 6 months (n=127).

†Snellen VA was converted from logMAR VA. A Snellen notation of 20/20-2 or better indicates a logMAR VA of 0.04 or better, which means 3 or more of the 5 ETDRS chart letters in the line were identified correctly.

1. AcrySof® IQ PanOptix® Directions for Use.

US-ACP-2000206

© 2020 Alcon Inc. 10/20

PanOptix is a trademark of Alcon. All other brand/product names are the trademarks of their respective owners.

Advertisement - Issue Continues Below
Publication Ad Publication Ad
End of Advertisement - Issue Continues Below